We are live on ! Find out more
NXTC icon

NextCure

88 hedge funds and large institutions have $1.14B invested in NextCure in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 29 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 6

227% more capital invested

Capital invested by funds: $348M → $1.14B (+$789M)

142% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 12

69% more funds holding

Funds holding: 5288 (+36)

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

1.99% more ownership

Funds ownership: 4.14%6.13% (+2%)

68% less call options, than puts

Call options by funds: $444K | Put options by funds: $1.37M

Holders
88
Holders Change
+36
Holders Change %
+69.23%
% of All Funds
1.73%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.06%
New
42
Increased
29
Reduced
12
Closed
6
Calls
$444K
Puts
$1.37M
Net Calls
-$927K
Net Calls Change
-$927K
Name Holding Trade Value Shares
Change
Change in
Stake
APM
26
Avidity Partners Management
Texas
$5.24M +$3.89M +7,750 New
PI
27
Putnam Investments
Massachusetts
$4.86M +$2.53M +5,034 +233%
N
28
Nuveen
North Carolina
$4.66M +$1.61M +3,210 +87%
Charles Schwab
29
Charles Schwab
California
$3.81M +$1.67M +3,322 +143%
Bank of America
30
Bank of America
North Carolina
$3.75M +$2.34M +4,667 +532%
Victory Capital Management
31
Victory Capital Management
Texas
$3.04M +$2.13M +4,253 +1,743%
Millennium Management
32
Millennium Management
New York
$2.96M +$2.19M +4,371 New
Bank of New York Mellon
33
Bank of New York Mellon
New York
$2.49M +$1.23M +2,445 +198%
EGI
34
EAM Global Investors
California
$2.35M -$473K -942 -21%
ICP
35
Indus Capital Partners
New York
$2.14M -$688K -1,371 -30%
VMI
36
VHCP Management II
New York
$2.04M +$1.52M +3,021 New
EI
37
EAM Investors
California
$1.82M -$366K -729 -21%
VIA
38
Vident Investment Advisory
Georgia
$1.71M +$1.27M +2,531 New
Morgan Stanley
39
Morgan Stanley
New York
$1.44M +$616K +1,227 +136%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$1.37M +$1.01M +2,022 New
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$1.21M +$704K +1,403 +361%
DCM
42
DAFNA Capital Management
California
$1.13M +$836K +1,667 New
Two Sigma Investments
43
Two Sigma Investments
New York
$1.07M +$797K +1,588 New
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$884K +$656K +1,308 New
Barclays
45
Barclays
United Kingdom
$872K +$570K +1,136 +738%
AGM
46
Alpine Global Management
New York
$822K +$610K +1,216 New
Squarepoint
47
Squarepoint
New York
$807K -$421K -839 -41%
Goldman Sachs
48
Goldman Sachs
New York
$777K +$282K +562 +96%
PPA
49
Parametric Portfolio Associates
Washington
$774K +$574K +1,145 New
JP Morgan Chase
50
JP Morgan Chase
New York
$752K +$517K +1,030 +1,256%

NXTC Hedge Fund Activity: Q4 2019 in Review

88 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in NextCure (NXTC) for Q4 2019, worth a combined $1.14B — up 227% from $348M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new NXTC positions and 6 closed out — a net gain of 36 holders — while 29 added to existing stakes and 12 trimmed.

The largest buyer was Great Point Partners, opening a new position worth an estimated $47.4M. The largest seller was Matthews International Capital Management, cutting an estimated $12.4M.

  • 88 institutional investors held NextCure (NXTC) as of Q4 2019, up from 52 in Q3 2019.
  • Funds reported $1.14B of NextCure stock for Q4 2019, up 227% quarter-over-quarter.
  • 42 funds opened new NextCure positions in Q4 2019 and 6 closed out, a net change of +36 holders.
  • The largest NextCure buyer in Q4 2019 was Great Point Partners, an estimated $47.4M added.
  • The largest NextCure seller in Q4 2019 was Matthews International Capital Management, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2019.